Hepatic Cell News Volume 7.06 | Feb 17 2023

    0
    18








    2023-02-17 | HCN 7.06


    Hepatic Cell News by STEMCELL Technologies
    Vol. 7.06 – 17 February, 2023
    TOP STORY

    Kupffer-Cell-Derived IL-6 Is Repurposed for Hepatocyte Dedifferentiation via Activating Progenitor Genes from Injury-Specific Enhancers

    Scientists uncovered that periportal-specific liver progenitor-like cell formation was initiated by regionally activated Kupffer cells but not peripheral monocyte-derived macrophages.
    [Cell Stem Cell]

    AbstractGraphical Abstract
    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    PUBLICATIONSRanked by the impact factor of the journal

    Bioengineered Liver Crosslinked with Nano-Graphene Oxide Enables Efficient Liver Regeneration via MMP Suppression and Immunomodulation

    Researchers demonstrated that scaffolds crosslinked with nano-graphene oxide show high resistance to enzymatic degradation via direct inhibition of matrix metalloproteinase activity and increased mechanical rigidity.
    [Nature Communications]

    Full Article

    The Genetic Background Shapes the Susceptibility to Mitochondrial Dysfunction and NASH Progression

    Investigators tested the susceptibility of seven mouse strains to develop non-alcoholic steatohepatitis (NASH). The severity of the clinical phenotypes observed varied widely across strains.
    [Journal of Experimental Medicine]

    Full Article

    Metformin-Induced TTP Mediates Communication between Kupffer Cells and Hepatocytes to Alleviate Hepatic Steatosis by Regulating Lipophagy and Necroptosis

    Hepatic steatosis was analyzed by Nile Red staining and measurement of inflammatory cytokines. Lipid accumulation and cell death were evaluated in co-culture systems with primary hepatocytes and Kupffer cells derived from either Ttp+/+ or Ttp−/− mice.
    [Metabolism Clinical And Experimental]

    Full ArticleGraphical Abstract

    Altered HLA-A2-Restricted TP53 Epitope Induces Specific CTL Cytotoxicity against Hepatocellular Carcinoma

    Researchers detected widespread expression of shared TP53-Y220C neoantigen in HCC with low affinity and low stability of binding to HLA-A0201 molecules.
    [European Journal of Immunology]

    Abstract

    CBX2-Mediated Suppression of SIAH2 Triggers WNK1 Accumulations to Promote Glycolysis in Hepatocellular Carcinoma

    The authors aimed to confirm the biological roles of seven in absentia homolog 2 (SIAH2) in liver cancer and provide potential therapeutic targets. Differential analysis was conducted based on public datasets and found that SIAH2 expressed lowly in HCC samples relative to normal tissues.
    [Experimental Cell Research]

    Abstract

    Upregulation of TUBG1 Expression Promotes Hepatocellular Carcinoma Development

    Investigators found that Tubulin γ-1 (TUBG1) was upregulated in human HCC cells and tissues and that TUBG1 upregulation was associated with promoter hypomethylation in HCC tissues.
    [Medical Oncology]

    Abstract

    NLRP3 Inflammasome Activation by 17β-Estradiol Is a Potential Therapeutic Target in Hepatocellular Carcinoma Treatment

    Scientists evaluated the role of NLRP3 inflammasome and pyroptosis in HCC and to clarify the potential mechanism by which 17β-estradiol could be used as a protective factor against HCC.
    [Medical Oncology]

    Full Article

    Mitochondrial Rupture after Photodamage Initiates Parkin-Independent Mitophagy in Mouse Hepatocytes

    Researchers used Airyscan super-resolution microscopy and correlative light-electron microscopy to characterize parkin association during photodamage-induced mitophagy, a form of phosphoinositide 3-kinase-independent or Type 2 mitophagy.
    [Biophysical Journal]

    Abstract
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    REVIEWS

    Targeting Tumor-Associated Macrophages in Hepatocellular Carcinoma: Biology, Strategy, and Immunotherapy

    Scientists describe the origin as well as phenotypic heterogeneity of tumor-associated macrophages (TAMs) and their potential effects on the occurrence and development of HCC and also discuss various adjuvant therapy-based strategies that can be used for targeting TAMs.
    [Cell Death Discovery]

    Full Article
    INDUSTRY AND POLICY NEWS

    Arrowhead Pharmaceuticals Gains Full Rights to NASH Candidate ARO-PNPLA3 with Promising Phase I Results

    Arrowhead Pharmaceuticals, Inc. announced that it has gained rights to ARO-PNPLA3, formerly called JNJ-75220795, which was part of a 2018 research collaboration and option agreement between Arrowhead and Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
    [Arrowhead Pharmaceuticals, Inc.]

    Press Release
    FEATURED EVENT

    OrganoidNL Symposium 2023

    March 31, 2023
    Amsterdam, The Netherlands

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Hepatitis C Virus Vaccine Research

    Twincore GmbH – Hannover, Germany

    Academic Position – Hepatology

    University of Alberta – Edmonton, Alberta, Canada

    Postdoctoral Associate – Liver Disease

    Baylor College of Medicine – Houston, Texas, United States

    Associate Professor – Department of Cell and Molecular Biology

    University of Mississippi Medical Center – Jackson, Mississippi, United States

    Postdoctoral Fellow – Liver Diseases

    University of Illinois Chicago – Chicago, Illinois, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter